[1] XIE W,WEI L,GUO J,et al.Physiological functions of wilms' tumor 1-associating protein and its role in tumourigenesis[J].J Cell Biochem,2019,120(7):10884-10892.
[2] GRATIAS EJ,DOME JS,JENNINGS LJ,et al.Association of chromosome 1q gain with Inferior survival in favorable-histology wilms tumor:a report from the children's oncology group[J].J Clin Oncol,2016,34(26):3189-3194.
[3] DOME JS,GRAF N,GELLER JI,et al.Advances in wilms tumor treatment and biology:progress through international collaboration[J].J Clin Oncol,2015,33(27):2999-3007.
[4]杨文萍,武海燕,张文,等.儿童肾母细胞瘤病理诊断共识[J].中华病理学杂志,2017,046(003):149-154.
YANG WP,WU HY,ZHANG W,et al.Expert consensus on pediatric nephroblastoma[J].Chinese Journal of Pathology,2017,046(003):149-154.
[5]廖玮玮,何志旭,冉立.1147例儿童实体瘤临床特征分析[J].贵州医科大学学报,2017,42(10):1227-1232.
LIAO WW,HE ZX,RAN L.Clinical analysis of 1147 solid tumor in children[J].Journal of Guizhou Medecine University,2017,42(10):1227-1232.
[6] 中华医学会小儿外科学分会泌尿外科学组.儿童肾母细胞瘤诊疗专家共识[J].中华小儿外科杂志,2020,41(07):585-590.
Group of Urological Surgery,Branch of Pediatric Surgery,Chinese Medical Association.Expert Consensus on Pediatric Nephroblastoma[J].Chinese Journal of Pediatric Surgery,2020,41(07):585-590.
[7] SALTZMAN AF,COST NG,ROMAO RLP.Wilms tumor[J].Urol Clin North Am,2023,50(3):455-464.
[8] 何丽,徐松,张眉,等.腹膜后畸胎瘤样肾母细胞瘤1例[J].实用放射学杂志,2021,37(8):1401-1402.
HE L,XU S,ZHANG M,et al.One case:retroperitoneal teratoid wilms tumor[J].J Pract Radiol,2021,37(8):1401-1402.
[9]李艳华,蒋莎义,廖雪莲,等.16例儿童横纹肌样瘤的临床特点及其诊治分析[J].山东医药,2020,60(16):72-74.
LI YH,JIANG SY,LIAO XL,et al.Analysis of clinical characteristics and their diagnosis and treatment of 16 cases malignant rhabdomyosarcoma in childhood[J].Shandong Medical Journal,2020,60(16):72-74.
[10] 金汝佳,王青杰,马怡晖.儿童恶性横纹肌样瘤9例临床病理分析[J].临床与实验病理学杂志,2020,36(10):1209-1211.
JIN RJ,WANG QJ,MA YH.Clinicopathologic analysis of 9 cases malignant rhabdomyosarcoma in childhood[J].J Clin Exp pathol,2020,36(10):1209-1211.
[11] 王亚楠,田亚明,许艳平,等.儿童肾母细胞瘤的临床病理特征及预后影响因素分析[J].实用癌症杂志,2022,37(4):653-655.
WANG YN,TIAN YM,XU YP,et al.Analysis of clinicopathological characteristics and prognostic influencing factors of pediatric nephroblastoma[J].The Practical Journal of Cancer,2022,37(4):653-655.
[12]储婧.儿童肾母细胞瘤临床病理资料与预后的影响因素分析[J].临床泌尿外科杂志,2023,38(4):260-264.
CHU J.Analysis of clinicopathological characteristics and prognostic influencing factors of pediatric nephroblastoma[J].Journal of Clinical Urology,2023,38(4):260-264.
[13]赵利敏.儿童肾母细胞瘤预后的危险因素分析[J].罕少疾病杂志,2023,30(4):67-68.
ZHAO LM.Analysis of the risk factors for the prognosis of pediatric nephroblastoma[J].Journal of Rare and Uncommon Diseases,2023,30(4):67-68.
[14]洪博,董瑞.肾母细胞瘤治疗研究进展[J].临床小儿外科杂志,2021,20(6):569-575.
HONG B,DONG R.Recent advances in the treatment of wilms tumor[J].J Clin Ped Sur,2021,20(6):569-575.
[15] KUMAR SAS.Is pre-operative chemotherapy desirable in all patients of wilms' tumor[J].Indian Journal of Pediatrics,2017,84(9):709-714.
[16] 张伟令,胡慧敏,黄东生,等.儿童肾母细胞瘤39例临床分析[J].中国医学前沿杂志(电子版),2019,11(11):46-49.
ZHANG WL,HU HM,HUANG DS,et al.Clinical analysis of 39 children with nephroblastoma[J].Chinese Journal of the Frontiers of Medical Science(Electronic Version),2019,11(11):46-49.
[17] ALDRINK JH,HEATON TE,DASGUPTA R,et al.Update on wilms tumor[J].J Pediatr Surg,2019,54(3):390-397.
[18] DOME JS,PERLMAN EJ,GRAF N.Risk stratification for wilms tumor:current approach and future directions[J].American Society of Clinical Oncology Educational Book,2014,34(1):215-223.
[19]CONTE B,SHEN C,THOMPSON,et al.Long-term outcomes after abdominal radiation for wilms tumor:A 20-year experience[J].American Journal of Clinical Oncology,2024,47(3):128-131.
[20] WU XW,ZHOU PP,DONG Q.Survival assessment of nephron-sparing surgery or radical nephrectomy in children with unilateral wilms tumor receiving adjuvant chemotherapy:a retrospective cross-sectional study[J].European Review for Medical and Pharmacological Sciences,2024,28(3):1095-1102.
[21] IRTAN S,EHRICH PF,Pritchard JK.Wilms tumor:"state-of-the-art" update[J].Semin Pediatr Surg,2016,25(5):250-256.